Nexcelom

Nexcelom Bioscience, now part of Revvity, is a developer and marketer of image cytometry products for cell analysis in life science and biomedical research. Products range from cell viability counters (Cellometer) to high throughput microwell image cytometry workstations (Celigo), used in thousands of research laboratories in academic institutes, and pharmaceutical and biotech companies. The company contributes to the life science industry through innovation and expertise in the science of cell counting. The product family includes instruments, consumables and reagents. Nexcelom customers engage in a wide variety of research, such as cancer research, immunology, stem cell research, and neuroscience. Nexcelom offers...

Cell counting,image cytometry,cell-based assay,customer support,image analysis,kinetic cell based assays,immunooncology,live cell imaging,3d culture models,high throughput screening,multiplexed immunofluorescence assays,cell analysis,and automated cell counting

Nexcelom operates in the Biotechnology research industry.

Nexcelom's revenue is 11m - 100m

Nexcelom has 11 - 50 employees.